Works by BERTAGNOLLI, MONICA M.


Results: 41
    1
    2

    The Oncology QCARD Initiative: Fostering efficient evaluation of initial real‐world data proposals.

    Published in:
    Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 11, p. 1, doi. 10.1002/pds.5818
    By:
    • Rivera, Donna R.;
    • Eckert, Joy C.;
    • Rodriguez‐Watson, Carla;
    • Lerro, Catherine C.;
    • Bertagnolli, Monica M.;
    • Hubbard, Rebecca A.;
    • Kushi, Lawrence H.;
    • Lund, Jennifer L.;
    • Schrag, Deborah;
    • Wang, Shirley V.;
    • Wood, William A.;
    • Lee, Jennifer J.;
    • Okafor, Cristeen;
    • Ghauri, Kanwal;
    • Winckler, Susan C.;
    • Kluetz, Paul G.
    Publication type:
    Article
    3
    4
    5

    A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803.

    Published in:
    Oncologist, 2017, v. 22, n. 1, p. 107, doi. 10.1634/theoncologist.2016-0215
    By:
    • Niedzwiecki, Donna;
    • Hasson, Rian M.;
    • Lenz, Heinz‐Josef;
    • Ye, Cynthia;
    • Redston, Mark;
    • Ogino, Shuji;
    • Fuchs, Charles S.;
    • Compton, Carolyn C.;
    • Mayer, Robert J.;
    • Goldberg, Richard M.;
    • Colacchio, Thomas A.;
    • Saltz, Leonard B.;
    • Warren, Robert S.;
    • Bertagnolli, Monica M.
    Publication type:
    Article
    6
    7
    8
    9
    10

    Laparoscopic colectomy for cancer.

    Published in:
    Journal of Surgical Oncology, 1995, v. 58, n. 4, p. 211, doi. 10.1002/jso.2930580402
    By:
    • Bertagnolli, Monica M.;
    • Decosse, Jerome J.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST.

    Published in:
    2022
    By:
    • Schaefer, Inga-Marie;
    • Hemming, Matthew L.;
    • Lundberg, Meijun Z.;
    • Serrata, Matthew P.;
    • Goldaracena, Isabel;
    • Liu, Ninning;
    • Yin, Peng;
    • Paulo, Joao A.;
    • Gygi, Steven P.;
    • George, Suzanne;
    • Morgan, Jeffrey A.;
    • Bertagnolli, Monica M.;
    • Sicinska, Ewa T.;
    • Chu, Chen;
    • Zheng, Shanshan;
    • Mariño-Enríquez, Adrian;
    • Hornick, Jason L.;
    • Raut, Chandrajit P.;
    • Ou, Wen-Bin;
    • Demetri, George D.
    Publication type:
    journal article
    21

    Modernizing Research and Evidence Consensus Definitions: A Food and Drug Administration–National Institutes of Health Collaboration.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 6, p. e2516674, doi. 10.1001/jamanetworkopen.2025.16674
    By:
    • Rivera, Donna R.;
    • Cutler, Tracy L.;
    • McShane, Lisa;
    • Meeker-O'Connell, Ann;
    • Marston, Hilary D.;
    • Califf, Robert M.;
    • Bertagnolli, Monica M.;
    • Avilés-Santa, Larissa;
    • Ayalew, Kassa;
    • Bayha, Ryan;
    • Chetta, Joshua;
    • Concato, John;
    • Culp, Michelle;
    • Dodd, Lori;
    • Facey, Natasha;
    • Forshee, Richard;
    • Freedman, Andrew;
    • Friedman, Philipa;
    • Golfinopoulos, Elisa;
    • Grandinetti, Cheryl
    Publication type:
    Article
    22

    Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.

    Published in:
    2017
    By:
    • Venook, Alan P.;
    • Niedzwiecki, Donna;
    • Lenz, Heinz-Josef;
    • Innocenti, Federico;
    • Fruth, Briant;
    • Meyerhardt, Jeffrey A.;
    • Schrag, Deborah;
    • Greene, Claire;
    • O'Neil, Bert H.;
    • Atkins, James Norman;
    • Berry, Scott;
    • Polite, Blase N.;
    • O'Reilly, Eileen M.;
    • Goldberg, Richard M.;
    • Hochster, Howard S.;
    • Schilsky, Richard L.;
    • Bertagnolli, Monica M.;
    • El-Khoueiry, Anthony B.;
    • Watson, Peter;
    • Benson III, Al B.
    Publication type:
    journal article
    23
    24
    25
    26
    27
    28

    MRE11-Deficiency Associated with Improved Long-Term Disease Free Survival and Overall Survival in a Subset of Stage III Colon Cancer Patients in Randomized CALGB 89803 Trial.

    Published in:
    PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0108483
    By:
    • Pavelitz, Thomas;
    • Renfro, Lindsay;
    • Foster, Nathan R.;
    • Caracol, Amber;
    • Welsch, Piri;
    • Lao, Victoria Valinluck;
    • Grady, William B.;
    • Niedzwiecki, Donna;
    • Saltz, Leonard B.;
    • Bertagnolli, Monica M.;
    • Goldberg, Richard M.;
    • Rabinovitch, Peter S.;
    • Emond, Mary;
    • Monnat Jr, Raymond J.;
    • Maizels, Nancy
    Publication type:
    Article
    29
    30

    Current Activities of the Coalition of Cancer Cooperative Groups.

    Published in:
    2019
    By:
    • Bertagnolli, Monica M;
    • Blaney, Susan M;
    • Blanke, Charles D;
    • Curran, Walter J;
    • Dancey, Janet;
    • Mannel, Robert S;
    • O'Dwyer, Peter J;
    • Schnall, Mitchell D;
    • Wolmark, Norman;
    • Groups, Coalition of Cancer Cooperative;
    • Coalition of Cancer Cooperative Groups
    Publication type:
    journal article
    31

    Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 23, p. 1789, doi. 10.1093/jnci/djt298
    By:
    • Ogino, Shuji;
    • Liao, Xiaoyun;
    • Imamura, Yu;
    • Yamauchi, Mai;
    • McCleary, Nadine J.;
    • Ng, Kimmie;
    • Niedzwiecki, Donna;
    • Saltz, Leonard B.;
    • Mayer, Robert J.;
    • Whittom, Renaud;
    • Hantel, Alexander;
    • Benson, Al B.;
    • Mowat, Rex B.;
    • Spiegelman, Donna;
    • Goldberg, Richard M.;
    • Bertagnolli, Monica M.;
    • Meyerhardt, Jeffrey A.;
    • Fuchs, Charles S.
    Publication type:
    Article
    32

    Relationship Between Statin Use and Colon Cancer Recurrence and Survival: Results From CALGB 89803.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1540
    By:
    • Ng, Kimmie;
    • Ogino, Shuji;
    • Meyerhardt, Jeffrey A.;
    • Chan, Jennifer A.;
    • Chan, Andrew T.;
    • Niedzwiecki, Donna;
    • Hollis, Donna;
    • Saltz, Leonard B.;
    • Mayer, Robert J.;
    • Benson, Al B.;
    • Schaefer, Paul L.;
    • Whittom, Renaud;
    • Hantel, Alexander;
    • Goldberg, Richard M.;
    • Bertagnolli, Monica M.;
    • Venook, Alan P.;
    • Fuchs, Charles S.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

    Published in:
    Clinical Trials, 2021, v. 18, n. 1, p. 104, doi. 10.1177/1740774520975120
    By:
    • Basch, Ethan;
    • Becker, Claus;
    • Rogak, Lauren J;
    • Schrag, Deborah;
    • Reeve, Bryce B;
    • Spears, Patricia;
    • Smith, Mary Lou;
    • Gounder, Mrinal M;
    • Mahoney, Michelle R;
    • Schwartz, Gary K;
    • Bennett, Antonia V;
    • Mendoza, Tito R;
    • Cleeland, Charles S;
    • Sloan, Jeff A;
    • Bruner, Deborah Watkins;
    • Schwab, Gisela;
    • Atkinson, Thomas M;
    • Thanarajasingam, Gita;
    • Bertagnolli, Monica M;
    • Dueck, Amylou C
    Publication type:
    Article
    39

    Rejoinder.

    Published in:
    Clinical Trials, 2020, v. 17, n. 3, p. 251, doi. 10.1177/1740774520913848
    By:
    • Bertagnolli, Monica M;
    • Anderson, Brian;
    • Quina, Andre;
    • Piantadosi, Steven
    Publication type:
    Article
    40
    41